Satonomics

2.5R Trade on Ajanta Pharma. 42% upside possiblity

Long
NSE:AJANTPHARM   AJANTA PHARMA
Break of Trendline which has been haunting Ajanta Pharma for 3 years (since 2016).

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.